229 related articles for article (PubMed ID: 27076853)
1. CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.
Lee YY; Wu WJ; Huang CN; Li CC; Li WM; Yeh BW; Liang PI; Wu TF; Li CF
J Cancer; 2016; 7(6):711-21. PubMed ID: 27076853
[TBL] [Abstract][Full Text] [Related]
2. INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
Lee HY; Li CC; Huang CN; Li WM; Yeh HC; Ke HL; Yang KF; Liang PI; Li CF; Wu WJ
J Surg Oncol; 2015 Mar; 111(4):414-22. PubMed ID: 25488476
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.
Lee YY; Wang CT; Huang SK; Wu WJ; Huang CN; Li CC; Chan TC; Liang PI; Hsing CH; Li CF
J Cancer; 2016; 7(15):2187-2196. PubMed ID: 27994654
[No Abstract] [Full Text] [Related]
4. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
[TBL] [Abstract][Full Text] [Related]
5. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
[TBL] [Abstract][Full Text] [Related]
6. CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Lin VC; He HL; Hsu CT; Li CC; Wu WJ; Huang CN; Wu TF; Li CF
Am J Transl Res; 2015; 7(4):710-22. PubMed ID: 26064439
[TBL] [Abstract][Full Text] [Related]
7. Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder.
Chang IW; Wang YH; Wu WJ; Liang PI; Li WM; Yeh BW; Wu TF; He HL; Huang SK; Li CF
J Cancer; 2016; 7(3):304-13. PubMed ID: 26918044
[TBL] [Abstract][Full Text] [Related]
8. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
[TBL] [Abstract][Full Text] [Related]
9. Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract.
Lee HY; Yeh BW; Chan TC; Yang KF; Li WM; Huang CN; Ke HL; Li CC; Yeh HC; Liang PI; Shiue YL; Wu WJ; Li CF
Oncotarget; 2017 Jul; 8(29):47216-47229. PubMed ID: 28525382
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
[TBL] [Abstract][Full Text] [Related]
11. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Liang PI; Wang YH; Wu TF; Wu WR; Liao AC; Shen KH; Hsing CH; Shiue YL; Huang HY; Hsu HP; Chen LT; Lin CY; Tai C; Wu JY; Li CF
J Clin Pathol; 2013 Jul; 66(7):573-82. PubMed ID: 23539739
[TBL] [Abstract][Full Text] [Related]
13. HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
Chang IW; Liang PI; Li CC; Wu WJ; Huang CN; Lin VC; Hsu CT; He HL; Wu TF; Hung CH; Li CF
Tumour Biol; 2015 Jul; 36(7):5441-50. PubMed ID: 25934334
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the cytochrome P450 4B1 protein confers a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
Lin JT; Chan TC; Li CF; Huan SKH; Tian YF; Liang PI; Pan CT; Shiue YL
APMIS; 2019 Apr; 127(4):170-180. PubMed ID: 30803053
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma.
Kuo YH; Lai HY; Chan TC; Hsing CH; Huang SK; Hsieh KL; Chen TJ; Li WS; Lu JC; Li CF
Onco Targets Ther; 2022; 15():727-740. PubMed ID: 35795328
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma.
Li WM; Chan TC; Huang SK; Wu WJ; Ke HL; Liang PI; Wei YC; Shiue YL; Li CF
Front Oncol; 2020; 10():570340. PubMed ID: 33194662
[No Abstract] [Full Text] [Related]
17. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
[TBL] [Abstract][Full Text] [Related]
18. SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma.
Chuang HW; Hsia KT; Liao JB; Yeh CC; Kuo WT; Yang YF
Diagnostics (Basel); 2021 Oct; 11(10):. PubMed ID: 34679626
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma.
Yeh CF; Chan TC; Ke HL; Chen TJ; Wu LC; Lee HY; Wei YC; Wu WJ; Li CF; Li WM
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440262
[TBL] [Abstract][Full Text] [Related]
20. BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Wu WJ; Wang YH; Wu TF; Liang PI; He HL; Yeh BW; Li CF
Histopathology; 2016 Mar; 68(4):520-32. PubMed ID: 26173071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
